Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Comis

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetics of carminomycin in dogs and humans. Preliminary reportS D Reich, S E Fandrich, T T Finkelstein, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1984
Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lungJ A Meyer, J J Gullo, P M Ikins, et al.
Cancer Treatment Reports|August 1, 1979
Long-term survivorship in small-cell anaplastic lung carcinomaS J Ginsberg, R L Comis, A J Gottlieb, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancerP J O'Dwyer, C J Langer, J Walczak, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approachC J Langer, N Rosenblum, M Hogan, et al.
Cancer Research|July 15, 1989
Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugateL M Weiner, J O'Dwyer, J Kitson, et al.
American Journal of Clinical Oncology|April 1, 1991
Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluationD S Ettinger, J D Bitran, R L Comis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell diseaseF J Cummings, K Kim, R S Neiman, et al.
Journal of the National Cancer Institute|September 4, 1991
Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine riboside: optimization of 6-methylmercaptopurine riboside dose and schedule through biochemical analysis of sequential tumor biopsy specimensP J O'Dwyer, G R Hudes, J Colofiore, et al.
Cancer Treatment Reports|January 1, 1983
Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ)R W Carey, R L Comis, D Anbar, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetics of carminomycin in dogs and humans. Preliminary reportS D Reich, S E Fandrich, T T Finkelstein, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 1, 1984
Adverse prognostic effect of N2 disease in treated small cell carcinoma of the lungJ A Meyer, J J Gullo, P M Ikins, et al.
Cancer Treatment Reports|August 1, 1979
Long-term survivorship in small-cell anaplastic lung carcinomaS J Ginsberg, R L Comis, A J Gottlieb, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of weekly 5-fluorouracil, cisplatin and vinblastine in advanced non-small cell lung cancerP J O'Dwyer, C J Langer, J Walczak, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Intraperitoneal cisplatin and etoposide in peritoneal mesothelioma: favorable outcome with a multimodality approachC J Langer, N Rosenblum, M Hogan, et al.
Cancer Research|July 15, 1989
Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugateL M Weiner, J O'Dwyer, J Kitson, et al.
American Journal of Clinical Oncology|April 1, 1991
Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluationD S Ettinger, J D Bitran, R L Comis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell diseaseF J Cummings, K Kim, R S Neiman, et al.
Journal of the National Cancer Institute|September 4, 1991
Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine riboside: optimization of 6-methylmercaptopurine riboside dose and schedule through biochemical analysis of sequential tumor biopsy specimensP J O'Dwyer, G R Hudes, J Colofiore, et al.
Cancer Treatment Reports|January 1, 1983
Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ)R W Carey, R L Comis, D Anbar, et al.
Pageof 12